(c) 2024 PillSync.com

24 HR tolterodine tartrate 2 MG Extended Release Oral Capsule

1 INDICATIONS AND USAGE Tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see Clinical Studies (14) ] . Tolterodine tartrate extended-release capsules are an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ( 1 )

Mylan Pharmaceuticals Inc.


4 years ago CAPSULE GREEN MYLAN 3402 24 HR tolterodine tartrate 2 MG Extended Release Oral Capsule

CAPSULE GREEN MYLAN 3402

16 HOW SUPPLIED/STORAGE AND HANDLING Tolterodine Tartrate Extended-Release capsules are available containing 2 mg or 4 mg of tolterodine tartrate, USP. The 2 mg capsules are hard-shell gelatin capsules with a green opaque cap and green opaque body filled with white to off-white beads. The capsules are axially printed with MYLAN over 3402 in black ink on the cap and body. They are available as follows: NDC 0378-3402-93 bottles of 30 capsules NDC 0378-3402-05 bottles of 500 capsules The 4 mg capsules are hard-shell gelatin capsules with a powder blue opaque cap and powder blue opaque body filled with white to off-white beads. The capsules are axially printed with MYLAN over 3404 in black ink on the cap and body. They are available as follows: NDC 0378-3404-93 bottles of 30 capsules NDC 0378-3404-05 bottles of 500 capsules Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.


More pills like CAPSULE MYLAN 3402












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site